Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With the Absence of Obstructive Coronary Artery Disease As Confirmed by Thermodilution-Derived CFR

NCT06139094 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT06139094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06139094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With the Absence of Obstructive Coronary Artery Disease As Confirmed by Thermodilution-Derived CFR
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Completed
Start date
December 20, 2023
Completion date
May 13, 2024
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

angina, coronary microvascular disease, ischemic heart disease